Frost & Sullivan has released its first comprehensive industry report focused on AI for Life Sciences (AI4LS), the 2025 China AI4LS Industry Blue Paper. The report provides a systematic evaluation of DIVAMICS, a representative AI-driven enterprise in drug discovery, highlighting its cross-disciplinary innovations in artificial intelligence, quantum mechanics, and molecular simulation, as well as its underlying technology architecture, platform capabilities, and business model.

DIVAMICS has officially joined Johnson & Johnson’s Global Incubator Network — JLABS Shanghai. As a leading global life science innovation platform, JLABS provides companies with a compliant, secure research environment and access to an international innovation network. The residency will support DIVAMICS in enhancing efficiency across AI- and molecular dynamics–driven early drug discovery, particularly in advancing programs from Hits (initial active molecules) to PCC (preclinical candidate compo

A joint study by DIVAMICS and Wuhan University of Technology has been published in the international journal Scientific Reports. Using the AlphaFold3-predicted structure of human tyrosinase (hTYR), the research team combined molecular docking and long-timescale molecular dynamics simulations to systematically investigate the binding modes of several natural whitening ingredients with hTYR. The work provides new mechanistic insights into how these compounds interact with the human enzyme and offe